MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones +10.3% ·
nuevas posiciones netas +7.1%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.35M | $201.57M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | — |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | — | — |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | — | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | — |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | — | −2 |
| Q2 2024 | 14 | — | 7.86M | $54.46M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 3.27M | — | $31.46M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 2.78M | -0.5% | $26.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.78M | -0.5% | $26.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 1.80M | +18.4% | $17.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 634.97K | +10.1% | $6.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 445.83K | 0.0% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 445.83K | 0.0% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 417.90K | +493.6% | $4.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 395.91K | -18.9% | $3.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 389.71K | +22.8% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 389.71K | +22.8% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 389.71K | +22.8% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 389.71K | +22.8% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 362.48K | +484.2% | $3.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Marshall Wace ✦ | 348.75K | +0.1% | $3.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 348.75K | +0.1% | $3.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 273.00K | -6.5% | $2.63M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 242.94K | +87.2% | $2.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 242.94K | +87.2% | $2.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 46.45K | +18.3% | $447,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 10.08K | Nuevo | $96,950 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 10.08K | Nuevo | $96,950 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 10.08K | Nuevo | $96,950 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| AQR Capital Management | $96,950 | 0.0% |
| AQR Capital Management | $96,950 | 0.0% |
| AQR Capital Management | $96,950 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 234 tenedores, 112.82M acciones, $439.18M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.